VR Logo

Parnax Lab Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1982

Chairman: Prakash M Shah

Managing Director: Baiju M Shah

Group: --

Listing: BSE: 506128

Headquarters: Mumbai, Maharashtra

Website: www.naxparlab.com

Key Facts

Market cap: R 15.65 Cr

Revenue (TTM): R 91.96 Cr

Earnings (TTM): R -1.09 Cr

Cash: R 0.60 Cr

Total Debt: R 41.94 Cr

Promoters' ownership: 62.59%

Liquidity: Low

52 Week range: R 11.65 - 31.00

Face value: R10.00

Shares outstanding: 85,04,866

10 Years Aggregate:

  • CFO: 43.90 Cr
  • EBITDA: 70.33 Cr
  • Net Profit: 16.15 Cr

Stock Performance

Time Period Parnax Lab Ltd. S&P BSE Healthcare* S&P BSE Small Cap*
YTD8.2416.51-20.49
1 month-5.202.05-1.88
3 months31.4316.07-20.54
1 Year-36.3917.60-26.73
3 Years-31.724.88-10.29
5 Years-7.65-1.53-0.70
10 Years--11.042.45
As on 01-Jun-2020 *As on 29-May-2020
Year Parnax Lab Ltd. S&P BSE Small Cap S&P BSE Healthcare
2019-62.26-6.85-3.55
2018-24.90-23.41-5.89
201787.4259.640.49
2016-47.421.77-12.88
201585.626.7615.06
2014-42.2069.2447.43
2013-11.46-11.2322.55